Group | P-Value | OR | 95% CI for OR | |||
---|---|---|---|---|---|---|
Control | Patient | Lower | Upper | |||
XRCC1 rs1799782 G > A | ||||||
Genotype | ||||||
GG | 45 (48.9%) | 47 (51.1%) | – | 1 | – | – |
GA | 0 (0.0%) | 0 (0.0%) | – | – | – | – |
AA | 5 (62.5%) | 3 (37.5%) | 0.465 | 0.574 | 0.130 | 2.545 |
Dominant model | ||||||
GA + AA | 5 (62.5% | 3 (37.5%) | 0.465 | 0.574 | 0.130 | 2.545 |
Recessive model | ||||||
GG + GA | 45 (48.9%) | 47 (51.1%) | 0.465 | 1.74 | 0.393 | 7.713 |
Allele | ||||||
G | 90 (48.9%) | 94 (51.1%) | – | 1 | – | – |
A | 10 (62.5%) | 6 (37.5%) | 0.297 | 0.574 | 0.201 | 1.646 |
NBN rs709816 A > G | ||||||
Genotype | ||||||
AA | 21 (51.2%) | 20 (48.8) | – | 1 | – | – |
AG | 24 (52.2%) | 22 (47.8%) | 0.963 | 0.962 | 0.415 | 2.235 |
GG | 5 (38.5%) | 8 (61.5%) | 0.420 | 1.68 | 0.470 | 6.007 |
Dominant model | ||||||
AG + GG | 29 (49.2%) | 30 (50.8%) | 0.839 | 1.086 | 0.489 | 2.214 |
Recessive model | ||||||
AA + AG | 45 (51.7%) | 42 (48.3%) | 0.376 | 0.583 | 0.177 | 1.925 |
Allele | ||||||
A | 66 (51.5%) | 62 (48.4%) | – | 1 | – | – |
G | 34 (47.2%) | 38 (52.7%) | 0.556 | 1.190 | 0.667 | 2.121 |
NBN rs1805794 C > G | ||||||
Genotype | ||||||
CC | 28 (53.8%) | 24 (46.2%) | – | 1 | – | – |
CG | 22 (45.8%) | 26 (54.2%) | 0.42 | 1.378 | 0.628 | 3.029 |
GG | 0 (0.0%) | 0 (0.0%) | – | – | – | – |
Dominant model | ||||||
CG + GG | 22 (45.8%) | 26 (54.2%) | 0.423 | 1.378 | 0.628 | 3.029 |
Recessive model | ||||||
CC + CG | 50 (50.0%) | 50 (50.0%) | – | – | – | – |
Allele | ||||||
C | 78 (51.3%) | 74 (48.6) | – | 1 | – | – |
G | 22 (45.8%) | 26 (54.1%) | 0.508 | 1.246 | 0.650 | 2.388 |
NBN SNVs interaction | |||||
---|---|---|---|---|---|
B | P-Value | OR | 95% CI for OR | ||
Lower | Upper | ||||
rs709816 by rs1805794 | 1.119 | 0.336 | 3.062 | 0.313 | 29.948 |